Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study

Can Australia reach the World Health Organization Hepatitis C elimination goal by 2025 among HIV-positive gay and bisexual men?

(2019) David C Boettiger et al.   CLINICAL INFECTIOUS DISEASES

Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV

(2018) Pierre Pradat et al.   AIDS

National characteristics and trends in antiretroviral treatment in Australia can be accurately estimated using a large clinical cohort

(2018) Robin Huang et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia

(2018) B. Hajarizadeh et al.   JOURNAL OF VIRAL HEPATITIS

Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013–17

(2018) Martin Holt et al.   Lancet HIV

Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant

(2018) Juan Berenguer et al.   Open Forum Infectious Diseases

Reinfection by HCV following effective all-oral DAA therapy in HIV/HCV-coinfected individuals

(2018) Juan Berenguer et al.   AIDS

Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010–2015

(2017) Ruth Zimmermann et al.   JOURNAL OF HEPATOLOGY

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

(2017) Patrick Ingiliz et al.   JOURNAL OF HEPATOLOGY

Micro-elimination – A path to global elimination of hepatitis C

(2017) Jeffrey V. Lazarus et al.   JOURNAL OF HEPATOLOGY

Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study

(2017) Charles Béguelin et al.   LIVER INTERNATIONAL

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

(2017) Jason Grebely et al.   Nature Reviews Gastroenterology & Hepatology

Retrospective study of hepatitis C outcomes and treatment in HIV co-infected persons from the Australian HIV Observational Database

(2017) Rainer Puhr et al.   Sexual Health

HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs

(2017) Marianne Martinello et al.   Current HIV/AIDS Reports

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

(2017) Sarah Larney et al.   Lancet Global Health

Hepatitis C virus infection

(2017) Michael P. Manns et al.   Nature Reviews Disease Primers

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights

(2016) Natasha K. Martin et al.   CLINICAL INFECTIOUS DISEASES

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

(2016) Bryony Simmons et al.   CLINICAL INFECTIOUS DISEASES

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

(2016) Natasha K. Martin et al.   JOURNAL OF HEPATOLOGY

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis

(2016) Lucy Platt et al.   LANCET INFECTIOUS DISEASES

Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights

(2016) Matthias Götte et al.   Nature Reviews Gastroenterology & Hepatology

Hepatitis C virus treatment as prevention in people who inject drugs

(2015) Matthew Hickman et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden

(2015) Ida Lindström et al.   Infectious Diseases

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis

(2015) François M. J. Lamoury et al.   PLoS One

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

(2014) Colette J Smith et al.   LANCET

Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool

(2012) Conan K. Woods et al.   JOURNAL OF CLINICAL MICROBIOLOGY